Eli Lilly leads the weight loss market ahead of Novo Nordisk. Eli Lilly also has a more diversified lineup of products than ...

Eli Lilly (LLY) heads into 2026 with GLP-1 pricing and competition risks; oral GLP-1 race heats up and downside looms.

Eli Lilly working Humana to distribute obesity medications through employer-focused programs via CenterWell Pharmacy.

Novo Nordisk ( NVO +1.68%) was once the top player in the weight loss drug market. The company's medicine, Wegovy, ...

Despite Super Bowl rings and big plays, "Manning fatigue" may hurt his case. That would be a shame because Eli was a master ...